Sequential chemotherapy regimen of induction with panitumumab and paclitaxel followed by radiotherapy and panitumumab in patients with locally advanced head and neck cancer unfit for platinum derivatives. The phase II, PANTERA/TTCC-2010-06 study

Autor: J. Lambea Sorrosal, Grupo Español de Tratamiento de Tumores de Cabeza y Cuello, B. Cirauqui Cirauqui, A Lozano Borbalas, L. C. Iglesias Docampo, José A. Caballero, J Marruecos Querol, J M Ponce Ortega, M. Taberna Sanz, M. Plana Serrahima, I. Planas Toledano, E Ortega Izquierdo, Javier Martinez-Trufero, J C Adansa, I. Pajares Bernad, R. Mesia Nin, Jordi Rubió-Casadevall

Publikováno v: Clinical and Translational Oncology. 23:1666-1677

Sequential treatment of Panitumumab (Pb) plus Paclitaxel (Px) as induction treatment (IT) followed by concurrent bioradiotherapy (Bio–RT) with Pb may be an alternative for locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c792b41bdfce6fa7aa9d9a6c7234d459
https://doi.org/10.1007/s12094-021-02567-z

El uso de fentanilo transdérmico por una unidad de atención domiciliaria en pacientes oncológicos en el final de la vida

Autor: R. Lastra del Prado, M. C. Pérez-Caballero, E. Aguirre Ortega, J. Lambea Sorrosal, R. Andres Conejero, J. I. Mayordomo Cámara, A. Tres Sánchez, P. Escudero Emperador, A. Sáenz Cusi, D. Isla Casado, M. E. Ortega Izquierdo

Publikováno v: Oncología (Barcelona) v.28 n.10 2005
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname

PROPÓSITO: Se ha realizado un estudio observacional y retrospectivo para evaluar el modo de utilización y los efectos secundarios de fentanilo transdérmico (FTTS) en pacientes oncológicos en situación terminal. MATERIAL Y MÉTODOS: Se han evalua

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9ec74ce96e70f4d401bff355ab34923
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0378-48352005001000004

Bevacizumab alone or with chemotherapy in highly pretreated, relapsed, epithelial ovarian cancer patients

Autor: Cristina Maria Churruca, M. Beltran, Juan Cueva, M. E. Ortega-Izquierdo, Andrés Redondo, A. Arcusa Lanza, Antonio González-Martín, Isabel Bover, B. Ojeda, Ana Beatriz Sánchez-Heras, Elena García-Martínez, Beatriz Pardo, Ana Santaballa, A. Lopez-Rodriguez, Cristina Caballero, Pilar Lianes, A. Tibau, Jesús García-Donas, Antonio Casado, M. M. Gordon-Santiago

Publikováno v: Journal of Clinical Oncology. 29:e15590-e15590

e15590 Background: To evaluate the safety and efficacy of bevacizumab (BEV) alone or combined with chemotherapy (CT) in a compassive use program sponsored by the Spanish Ovarian Cancer Research Gro...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::834bd630455dc230c8d07a2d139a1209
https://doi.org/10.1200/jco.2011.29.15_suppl.e15590

Sequential therapy with induction chemotherapy and chemoradiotherapy in pre-irradiated recurrent head and neck squamous cell carcinoma incorporating nab-paclitaxel-a commentary of the phase I trial of AFHX followed by concomitant FHX scheme.

Autor: Martinez-Trufero J; Medical Oncology Department, University Hospital Miguel Servet, Zaragoza, Spain., Comin Orce A; Medical Oncology Department, University Hospital Miguel Servet, Zaragoza, Spain., Gomez Mugarza P; Medical Oncology Department, University Hospital Miguel Servet, Zaragoza, Spain., Barriendos Sanz S; Medical Oncology Department, University Hospital Miguel Servet, Zaragoza, Spain., Ortega Izquierdo E; Medical Oncology Department, University Hospital Miguel Servet, Zaragoza, Spain.

Publikováno v: Translational cancer research [Transl Cancer Res] 2023 Apr 28; Vol. 12 (4), pp. 692-696. Date of Electronic Publication: 2023 Apr 06.